home / stock / azrx / azrx news


AZRX News and Press, AzurRx BioPharma Inc. From 01/14/20

Stock Information

Company Name: AzurRx BioPharma Inc.
Stock Symbol: AZRX
Market: NASDAQ
Website: azurrx.com

Menu

AZRX AZRX Quote AZRX Short AZRX News AZRX Articles AZRX Message Board
Get AZRX Alerts

News, Short Squeeze, Breakout and More Instantly...

AZRX - APHA, GME among premarket losers

Stemline Therapeutics (NASDAQ: STML )  -22%  on preliminary Q4 revenue. More news on: Stemline Therapeutics, Inc., Avinger, Inc., DURECT Corporation, Stocks on the move, Read more ...

AZRX - AzurRx BioPharma Announces Closing of $6.9 Million Private Placement

NEW YORK, Jan. 13, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced the closing of ...

AZRX - 10 Penny Stocks To Watch This Week Presenting Key Data

Are Any Of These Penny Stocks On Your Watch List This Week? When it comes to penny stocks , it may be hard to plan ahead. But then you can’t forget that a few sectors are well-known for giving a preview of what’s to come. In this regard, I’d like to look at a few biotech...

AZRX - PTLA, NKTR, SRNE and SIX among midday movers

Gainers:  Sorrento Therapeutics (NASDAQ: SRNE )  +38% . More news on: Sorrento Therapeutics, Inc., Ultragenyx Pharmaceutical Inc., Venus Concept Inc., Stocks on the move, Read more ...

AZRX - AzurRx Bio up 33% ahead of MS1819-SD data

Thinly traded nano cap AzurRx BioPharma ( AZRX +32.7% ) is up on more than an 8x surge in volume in early trade ahead of its presentation of new data on lead candidate MS1819-SD on Monday, January 13, at 2020 Biotech Showcase in San Francisco. More news on: AzurRx BioPharma, Inc., Heal...

AZRX - SRNE, SEEL among premarket gainers

Sorrento Therapeutics (NASDAQ: SRNE ) +50%  on non-binding takeover bid . More news on: Sorrento Therapeutics, Inc., Aclaris Therapeutics, Inc., AzurRx BioPharma, Inc., Stocks on the move, Read more ...

AZRX - AzurRx BioPharma To Present Interim Phase 2 Clinical Study Data for MS1819-SD, in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency, at Biotech Showcase 2020 Conference (January 13) in San Francisco

Initial data from the first five patients indicate positive trends for all primary and secondary safety and efficacy endpoints in AzurRx’s Phase 2 Clinical Study for MS1819-SD, in combination with standard PERT for Cystic Fibrosis patients with severe exocrine pancreatic insufficien...

AZRX - 4 Penny Stocks To Buy Or Sell Ahead Of Employment Data?

Are These Penny Stocks On Your Friday Morning Watch List? Friday, January 10 marks the end of the first full week of 2020 and there are several economic reports to take into account. These include employment, nonfarm payrolls, and business inventories. These will all be reported throughout the...

AZRX - 3 Penny Stocks To Buy Or Sell This Week; 1 up 269% Since October

These Penny Stocks Have Broken Out Big This Week It is often said that the best way of making money in the stock market is by investing. While this may be true for many investors, you need to understand how to manage risk. As this is the case, some enjoy a higher-risk profile. Considering t...

AZRX - AzurRx BioPharma to Present at the Biotech Showcase 2020 Conference (January 13th)

BROOKLYN, N.Y., Jan. 06, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, announced today the Company wil...

Previous 10 Next 10